MTCR
Metacrine Inc

1,244
Mkt Cap
$24.75M
Volume
83,889.00
52W High
$0.5905
52W Low
$0.303
PE Ratio
-0.57
MTCR Fundamentals
Price
$0.0014
Prev Close
$0.589
Open
$0.5883
50D MA
$0.5625
Beta
0.78
Avg. Volume
48,854.36
P/B
0.67
Loading...
Loading...
Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Metacrine Inc?
What is the 52-week high for Metacrine Inc?
What is the 52-week low for Metacrine Inc?
What is Metacrine Inc stock price today?
What was Metacrine Inc stock price yesterday?
What is the PE ratio of Metacrine Inc?
What is the Price-to-Book ratio of Metacrine Inc?
What is the 50-day moving average of Metacrine Inc?

Latest MTCR News

View
No MTCR news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.